Viewing Study NCT05389293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:04 AM
Ignite Modification Date: 2026-01-31 @ 6:40 AM
Study NCT ID: NCT05389293
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2022-05-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Follicular Lymphoma View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mosunetuzumab View
None Follicular Lymphoma View
None Lymphoma View
None Memorial Sloan Kettering Cancer Center View
None 22-100 View